2,3-bis(3'-hydroxybenzyl)butyrolactone and Adenoma

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Adenoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arts, IC; Hollman, PC; Kampman, E; Kuijsten, A; van't Veer, P	1

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Adenoma

Article	Year
Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2006, Volume: 15, Issue:6 Topics: 4-Butyrolactone; Adenoma; Case-Control Studies; Chromatography, Liquid; Colorectal Neoplasms; Diet; Female; Humans; Incidence; Lignans; Middle Aged; Netherlands; Odds Ratio; Retrospective Studies; Spectrometry, Mass, Electrospray Ionization; Surveys and Questionnaires	2006

Article

Year

Plasma enterolignans are associated with lower colorectal adenoma risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2006, Volume: 15, Issue:6

Topics: 4-Butyrolactone; Adenoma; Case-Control Studies; Chromatography, Liquid; Colorectal Neoplasms; Diet; Female; Humans; Incidence; Lignans; Middle Aged; Netherlands; Odds Ratio; Retrospective Studies; Spectrometry, Mass, Electrospray Ionization; Surveys and Questionnaires

2006